Skip to main content

Table 1 Descriptive characteristics of women populations surveyed in German national health surveys before (1997–1999) and after (2003–2004) the publication of the EPT-WHI trial results

From: Differences in Menopausal Hormone Therapy Use among Women in Germany between 1998 and 2003

 

1997–1999 survey

2003–2004 survey

p-value

Sample size (unweighted total n)

2284 (2248)

2362 (2215)

 

Continuous variables, mean ± SD

   

Age, years

59.8 ± 12.0

60.0 ± 12.5

0.437

BMI, kg/m 2

27.8 ± 5.1

27.6 ± 5.2

0.566

Nominal and ordinal variables, n (%)

   

Residence in former West Germany

1762(77.1)

1841(77.9)

0.515

Social status

   

   Lower

691(31.8)

848(36.9)

< 0.001

   Intermediate

1115(51.4)

1003(43.7)

 

   Upper

364(16.8)

446(19.4)

 

Smoking status

   

   Smoker

405(18.4)

485(20.5)

< 0.001

   Ex-smoker

349(15.9)

538(22.8)

 

   Non-smoker

1447(65.7)

1339(56.7)

 

Physical activity

   

   0 hrs/wk

1277(58.4)

1135(48.6)

< 0.001

   < 1 hrs/wk

268(12.2)

232(9.9)

 

   1–2 hrs/wk

377(17.2)

503(21.5)

 

   > 2 hrs/wk

266(12.2)

466(19.9)

 

Pre-existing medical conditions (yes vs. no)

   

Diabetes

217(9.6)

228(9.7)

0.891

Hypertension

868(38.2)

950(40.4)

0.128

Hyperlipidemia

751(33.0)

881(37.5)

0.001

CVD

385(16.9)

355(15.3)

0.124

Current MHT use # , n (%)

386(16.9)

238(10.1)

< 0.001

   ≤ 1 year (new starters)

71(3.1)

16(0.7)

< 0.001

   1–3 years

81(3.5)

31(1.3)

< 0.001

   > 3 years (long-term users)

230(10.1)

189(8.0)

0.014

  1. All results are weighted to the distribution of main demographic characteristics (age, sex, residence in West or East Germany and level of urbanity) in the German population according to official population statistics at the time of the survey as well as in 2003.
  2. p-values are based on t-tests for continuous variables or χ2-tests for dichotomous variables.
  3. EPT-WHI = combined estrogen plus progestin therapy arm of the Women's Health Initiative randomized controlled trial; BMI = Body mass index; CVD = cardiovascular disease; hr(s)/wk = hour(s)/week; MHT = menopausal hormone therapy.
  4. # Information for duration of MHT use was missing in 4 users in the 1997–1999 survey and 2 users in the 2003–2004 survey.